| Literature DB >> 7690804 |
F Gotch1, S N McAdam, C E Allsopp, A Gallimore, J Elvin, M P Kieny, A V Hill, A J McMichael, H C Whittle.
Abstract
A preliminary study of gag-specific, MHC-restricted CD8+ CTL has been performed in nine Gambian patients infected with HIV2. Such CTL were present in at least 55% of patients in fresh peripheral blood mononuclear cells without the requirement for in vitro restimulation. We have identified a nonamer peptide from HIV2 gag that is recognized by CD8+ HLA-B53 CTL using an amino acid sequence motif predicted from analysis of endogenous peptides eluted from HLA-B53 molecules. This peptide, from an HIV2/SIV conserved sequence, has previously been reported to be recognized by CTL from non-human primates vaccinated with recombinant vaccinia virus expressing the gag protein of SIV or infected with SIV virus. HLA-B53-restricted, HIV2 gag-specific CTL did not recognize target cells expressing HIV1 gag proteins, indicating that no cellular cross protection to HIV1 could be expected in this case.Entities:
Mesh:
Substances:
Year: 1993 PMID: 7690804
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422